These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21898484)

  • 1. Immunization with aspartate-β-hydroxylase-loaded dendritic cells produces antitumor effects in a rat model of intrahepatic cholangiocarcinoma.
    Noda T; Shimoda M; Ortiz V; Sirica AE; Wands JR
    Hepatology; 2012 Jan; 55(1):86-97. PubMed ID: 21898484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of effector T cells against cholangiocarcinoma is enhanced by self-differentiated monocyte-derived dendritic cells.
    Panya A; Thepmalee C; Sawasdee N; Sujjitjoon J; Phanthaphol N; Junking M; Wongkham S; Yenchitsomanus PT
    Cancer Immunol Immunother; 2018 Oct; 67(10):1579-1588. PubMed ID: 30056600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response of dendritic cells acquiring antigens from apoptotic cholangiocarcinoma cells induced by mitomycin].
    Wu G; Han BL; Pei XT
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):149-52. PubMed ID: 12681060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.
    Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J
    J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns.
    Jiraviriyakul A; Songjang W; Kaewthet P; Tanawatkitichai P; Bayan P; Pongcharoen S
    World J Gastroenterol; 2019 Aug; 25(29):3941-3955. PubMed ID: 31413529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells.
    Thepmalee C; Panya A; Sujjitjoon J; Sawasdee N; Poungvarin N; Junking M; Yenchitsomanus PT
    Hum Vaccin Immunother; 2020 Oct; 16(10):2318-2327. PubMed ID: 31976810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
    Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
    Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
    Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma.
    Shimizu K; Kotera Y; Aruga A; Takeshita N; Takasaki K; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2012 Mar; 19(2):171-8. PubMed ID: 21874278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel "patient-like" model of cholangiocarcinoma progression based on bile duct inoculation of tumorigenic rat cholangiocyte cell lines.
    Sirica AE; Zhang Z; Lai GH; Asano T; Shen XN; Ward DJ; Mahatme A; Dewitt JL
    Hepatology; 2008 Apr; 47(4):1178-90. PubMed ID: 18081149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
    Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
    J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma.
    Hinkel A; Tso CL; Gitlitz BJ; Neagos N; Schmid I; Paik SH; deKernion J; Figlin R; Belldegrun A
    J Immunother; 2000 Jan; 23(1):83-93. PubMed ID: 10687141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures.
    Brasel K; De Smedt T; Smith JL; Maliszewski CR
    Blood; 2000 Nov; 96(9):3029-39. PubMed ID: 11049981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential gene expression profiling of cultured neu-transformed versus spontaneously-transformed rat cholangiocytes and of corresponding cholangiocarcinomas.
    Dumur CI; Campbell DJ; DeWitt JL; Oyesanya RA; Sirica AE
    Exp Mol Pathol; 2010 Dec; 89(3):227-35. PubMed ID: 20816680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells.
    Thepmalee C; Panya A; Junking M; Chieochansin T; Yenchitsomanus PT
    Hum Vaccin Immunother; 2018 Jun; 14(6):1423-1431. PubMed ID: 29420117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice.
    Wongkajornsilp A; Somchitprasert T; Butraporn R; Wamanuttajinda V; Kasetsinsombat K; Huabprasert S; Maneechotesuwan K; Hongeng S
    Cancer Invest; 2009 Feb; 27(2):140-8. PubMed ID: 19235585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent maturation of monocyte-derived dendritic cells after CD40L lentiviral gene delivery.
    Koya RC; Kasahara N; Favaro PM; Lau R; Ta HQ; Weber JS; Stripecke R
    J Immunother; 2003; 26(5):451-60. PubMed ID: 12973034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.
    Sadeghlar F; Vogt A; Mohr RU; Mahn R; van Beekum K; Kornek M; Weismüller TJ; Branchi V; Matthaei H; Toma M; Schmidt-Wolf IGH; Kalff JC; Strassburg CP; González-Carmona MA
    Cancer Immunol Immunother; 2021 May; 70(5):1451-1464. PubMed ID: 33180184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.